A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients A Study to Determine the Dose of WIN-1001Xby Evaluating Efficacy and Safety in Early Parkinson's Dis ...
A Clinical Study to Determine the Optimal Dose of WIN-1001X by Evaluating Its Efficacy and Safety in Patients With Early Parkinson's Disease: Double-blind, Randomized, Placebo-controlled, Multicenter, Phase II Study A Clinical Study to Determine the Optimal Dose of WIN-1001Xby Evaluating Its Efficacy and Safety in ...